NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/04/2026
Voltar para busca
Dado oficial do USPTO
MIKROGEN
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
40
Atualização mais recente
03/04/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 42
Data de depósito
27/06/2011
Data de registro
06/11/2012
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
22/03/2024
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
706
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
Neuried, DE
Examinador
CRAWFORD, MARY
Unidade examinadora
L20
Localização atual
GENERIC WEB UPDATE
Titulares e representantes
Titulares
Mikrogen GmbH
Mikrogen GmbH
Representantes
Chalin A. Smith Smith Patent Consulting
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Diagnostic agentsreagents and diagnostic preparations for scientific purposes; biochemical agents and preparationsreagentsfor scientific purposesin particular recombinantly produced proteins and peptides; chemical and biochemical reagents and genetic identity tests comprised of reagents for the identification of DNA by means of PCR technology and hybridization
Classe 5
Diagnostic agentsfor medical and pharmaceutical purposesmedical diagnostic reagents and radioactive pharmaceutical preparations for in vivo diagnostic use; biochemical agents and preparations for pharmaceutical purposespharmaceuticals for use in diagnosing bacterial and viral infectious diseases and autoimmune diseases; diagnostic agents for medical purposesrecombinantly or synthetically produced antigens for medicalin particular diagnostic purposes; diagnostic agents for medical purposeslysates of microorganismsin particular preparations of components of microorganisms usable for diagnostic purposes; diagnostic agents for carrying out serologic tests for medical purposes; biochemical preparations for carrying out verification tests for medical purposesdiagnosis of bacterial and viral infectious diseases and autoimmune diseases ; diagnostic preparations for medical usediagnostic preparations for carrying out western blot tests for medical purposes; diagnostic preparations for medical usediagnostic preparations for carrying out enzyme immune tests for medical purposes; diagnostic reagents for serologic test of infections for medical purposes
Classe 42
Services of a medicalbacteriological and biochemical laboratoryin particular chemical synthesis of oligonucleotides; scientific analysis regarding reagents and probes for the identification of DNA by means of PCR technology and hybridization; research and development services in the field of bacteriologycytologyantibody technologychemistryimmunology and gene expression systemsin particular regarding cloningexpression and purification of proteins and antigens for third parties; biochemical research and development for recombinant production of partially purified proteins of microorganisms
Publicações
Histórico de despachos e eventos da marca no USPTO.
40 publicações encontradas
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
22/03/2024
71AG
REGISTERED-SEC.71 ACCEPTED
22/03/2024
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
21/03/2024
PR71
POST REGISTRATION ACTION MAILED - SEC.71
15/11/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/11/2023
ES71
TEAS SECTION 71 RECEIVED
06/04/2023
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
06/11/2021
RNWL
INTERNATIONAL REGISTRATION RENEWED
16/07/2021
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
12/10/2018
71AG
REGISTERED-SEC.71 ACCEPTED
12/10/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
23/08/2018
ES71
TEAS SECTION 71 RECEIVED
08/08/2018
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
06/11/2017
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/06/2013
FICS
FINAL DISPOSITION NOTICE SENT TO IB
17/05/2013
FIMP
FINAL DISPOSITION PROCESSED
17/05/2013
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/02/2013
R.PR
REGISTERED-PRINCIPAL REGISTER
06/11/2012
GPNX
NOTIFICATION PROCESSED BY IB
30/09/2012
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
21/08/2012
PUBO
PUBLISHED FOR OPPOSITION
21/08/2012
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/08/2012
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/08/2012
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/08/2012
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
13/07/2012
ALIE
ASSIGNED TO LIE
12/07/2012
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
22/06/2012
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/06/2012
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
31/05/2012
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
31/05/2012
RFNT
REFUSAL PROCESSED BY IB
09/01/2012
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
22/12/2011
RFRR
REFUSAL PROCESSED BY MPU
22/12/2011
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
21/12/2011
CNRT
NON-FINAL ACTION WRITTEN
20/12/2011
MAFR
APPLICATION FILING RECEIPT MAILED
20/12/2011
DOCK
ASSIGNED TO EXAMINER
16/12/2011
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
16/12/2011
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
15/12/2011
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace MIKROGEN ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.